Cardiovascular Pathology
Volume 20, Issue 4 , Pages 222-231 , July 2011

Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes

  • Iwona Cicha

      Affiliations

    • Department of Cardiology and Angiology, Erlangen, Germany
    • Corresponding Author InformationCorresponding author. Laboratory of Molecular Cardiology, Department of Cardiology and Angiology, University of Erlangen-Nuremberg, Schwabachanlage 10, 91054 Erlangen, Germany. Tel.: +49 9131 8535896; fax: +49 9131 8532079.
    • ,
  • André Rüffer

      Affiliations

    • Department of Paediatric Cardiac Surgery, Erlangen, Germany
    • ,
  • Robert Cesnjevar

      Affiliations

    • Department of Paediatric Cardiac Surgery, Erlangen, Germany
    • ,
  • Martin Glöckler

      Affiliations

    • Department of Paediatric Cardiology, Erlangen, Germany
    • ,
  • Abbas Agaimy

      Affiliations

    • Institute of Pathology, University Erlangen-Nuremberg, Erlangen, Germany
    • ,
  • Werner G. Daniel

      Affiliations

    • Department of Cardiology and Angiology, Erlangen, Germany
    • ,
  • Christoph D. Garlichs

      Affiliations

    • Department of Cardiology and Angiology, Erlangen, Germany
    • ,
  • Sven Dittrich

      Affiliations

    • Department of Paediatric Cardiology, Erlangen, Germany

Received 8 January 2010 ,Revised 17 March 2010 ,Accepted 26 April 2010.

References 

  1. Wells WJ, Arroyo H, Bremner RM, Wood J, Starnes VA. Homograft conduit failure in infants is not due to somatic outgrowth. J Thorac Cardiovasc Surg. 2002;124:88–96
  2. Stark J, Bull C, Stajevic M, Jothi M, Elliot M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg. 1998;115:506–516
  3. Chan KC, Fyfe DA, McKay CA, Sade RM, Crawford FA. Right ventricular outflow reconstruction with cryopreserved homografts in pediatric patients: intermediate-term follow- up with serial echocardiographic assessment. J Am Coll Cardiol. 1994;24:483–489
  4. Koolbergen DR, Hazekamp MG, de Heer E, Bruggemans EF, Huysmans HA, Dion RA, et al. The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg. 2002;124:689–697
  5. Schreiber C, Sassen S, Kostolny M, Hörer J, Cleuziou J, Wottke M, et al. Early graft failure of small-sized porcine valved conduits in reconstruction of the right ventricular outflow tract. Ann Thorac Surg. 2006;82:179–185
  6. Ishizaka T, Ohye RG, Goldberg CS, Ramsburg SR, Suzuki T, Devaney EJ, et al. Premature failure of small-sized Shelhigh No-React porcine pulmonic valve conduit model NR-4000. Eur J Cardiothorac Surg. 2003;23:715–718
  7. Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann Thorac Surg. 2005;79:625–631
  8. Tiete AR, Sachweh JS, Roemer U, Kozlik-Feldmann R, Reichart B, Daebritz SH. Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution. Ann Thorac Surg. 2004;77:2151–2156
  9. Meyns B, Van Garsse L, Boshoff D, Eyskens B, Mertens L, Gewillig M, et al. The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J Thorac Cardiovasc Surg. 2004;128:834–840
  10. Butany J, Zhou T, Leong SW, Cunningham KS, Thangaroopan M, Jeggatheeswaran A, et al. Inflammation and infection in nine surgically explanted Medtronic Freestyle® stentless aortic valves. Cardiovasc Pathol. 2007;16:258–267
  11. Dittrich S, Alexi-Meskishvili VV, Yankah AC, Dähnert I, Meyer R, Hetzer R, et al. Comparison of porcine xenografts and homografts for pulmonary valve replacement in children. Ann Thorac Surg. 2000;70:717–722
  12. Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?. J Thorac Cardiovasc Surg. 1996;112:1170–1178
  13. Caldarone CA, McCrindle BW, Van Arsdell GS, Coles JG, Webb G, Freedom RM, et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg. 2000;120:1022–1031
  14. Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for homograft dysfunction and failure. Ann Thorac Surg. 2005;80:655–664
  15. Hawkins JA, Hillman ND, Lambert LM, Jones J, Di Russo GB, Profaizer T, et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg. 2003;126:247–252
  16. Konuma T, Devaney EJ, Bove EL, Gelehrter S, Hirsch JC, Tavakkol Z, et al. Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2009;88:849–854
  17. Dohmen PM, Lembcke A, Holinski S, Kivelitz D, Braun JP, Pruss A, et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg. 2007;84:729–736
  18. Dohmen PM, Costa F, Lopes SV, Yoshi S, Souza FP, Vilani R, et al. Results of a decellularized porcine heart valve implanted into the juvenile sheep model. Heart Surg Forum. 2005;8:E100–E104
  19. Dohmen PM, Hauptmann S, Terytze A, Konertz WF. In-vivo repopularization of a tissue-engineered heart valve in a human subject. J Heart Valve Dis. 2007;16:447–449
  20. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg. 2001;71(5 Suppl):S428–S432
  21. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002–1006
  22. Affonso da Costa FD, Dohmen PM, Lopes SV, Lacerda G, Pohl F, Vilani R, et al. Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep. Artif Organs. 2004;28:366–370
  23. Pearl JM, Cooper DS, Bove KE, Manning PB. Early failure of the Shelhigh pulmonary valve conduit in infants. Ann Thorac Surg. 2002;74:542–548
  24. Steffen CL, Ball-Mirth DK, Harding PA, Bhattacharyya N, Pillai S, Brigstock DR. Characterization of cell associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblasts cells in vitro. Growth Factors. 1998;15:199–213
  25. Courtman DW, Errett BF, Wilson GJ. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res. 2001;55:576–586
  26. Baskett RJ, Nanton MA, Warren AE, Ross DB. Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions. J Thorac Cardiovasc Surg. 2003;126:232–239
  27. Schreiber C, Eicken A, Seidl S, Lange R. Unexpected early failure of a decellularized right ventricle to pulmonary artery graft. Ann Thorac Surg. 2008;86:2026–2027
  28. Erdbrügger W, Konertz W, Dohmen PM, Posner S, Ellerbrok H, Brodde OE, et al. Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. Tissue Eng. 2006;12:2059–2068
  29. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med. 1994;180:2027–2037
  30. Leask A, Holmes A, Abraham DJ. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep. 2002;4:136–142
  31. Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B, et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation. 2005;111:2792–2797
  32. Bastian F, Stelzmüller ME, Kratochwill K, Kasimir MT, Simon P, Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials. 2008;29:1824–1832

 All authors of this manuscript are funded from institutional sources (University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany). The authors have no conflict of interest to disclose.

PII: S1054-8807(10)00067-0

doi: 10.1016/j.carpath.2010.04.006

Cardiovascular Pathology
Volume 20, Issue 4 , Pages 222-231 , July 2011

Article Tools

* Image Usage & Resolution